ArticleGlobal health & medicine2026
From fragmentation to integration: Can Japan's JIHS deliver a resilient system to deal with health emergencies?
Article in Global health & medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The establishment of the Japan Institute for Health Security (JIHS) in 2025 represents a major institutional reform aimed at enhancing Japan's preparedness for health emergencies in the aftermath of COVID-19. By integrating the National Institute of Infectious Diseases and the National Center for Global Health and Medicine, JIHS seeks to address the long-standing fragmentation of research, clinical practice, and public health responses. In its first year, the institute has made measurable progress in consolidating surveillance and clinical data systems and in expanding research and response networks. However, integration alone does not guarantee effectiveness. Critical challenges remain, including persistent workforce shortages, insufficient incentives for infectious disease research and development, and the complexity of aligning institutional cultures and operational frameworks. This editorial argues that the success of JIHS will depend not only on structural integration but also on sustained investment in human resources, governance reform, and cross-sector coordination. Japan's experience highlights both the promise and the limitations of centralized public health systems and provides important lessons for other countries seeking to build resilient systems to deal with health emergencies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.